Format

Send to

Choose Destination
See comment in PubMed Commons below
Acta Pharmacol Sin. 2012 Feb;33(2):173-81. doi: 10.1038/aps.2011.203.

Laboratory animals as surrogate models of human obesity.

Author information

1
Diabetes Research Unit, Novo Nordisk A/S, Beijing Novo Nordisk Pharmaceuticals Sci & Tech Co Ltd., Beijing, China.

Abstract

Obesity and obesity-related metabolic diseases represent a growing socioeconomic problem throughout the world. Great emphasis has been put on establishing treatments for this condition, including pharmacological intervention. However, there are many obstacles and pitfalls in the development process from pre-clinical research to the pharmacy counter, and there is no certainty that what has been observed pre-clinically will translate into an improvement in human health. Hence, it is important to test potential new drugs in a valid translational model early in their development. In the current mini-review, a number of monogenetic and polygenic models of obesity will be discussed in view of their translational character.

PMID:
22301857
PMCID:
PMC4010334
DOI:
10.1038/aps.2011.203
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center